1. Studies were carried out to test the assumptions involved in the calculation of free fatty acid (FFA) and triglyceride transport rates from the plasma radioactivity curves after the intravenous administration of labelled fatty acid or of pre-labelled lipoprotein triglyceride.
hypertriglyceridaemia can result from a change in plasma triglyceride influx, or in outflux, or in both. The entry of triglycerides into the plasma can be related to changes in plasma free fatty acid flux since, in man, plasma free fatty acid (FFA) serves as the main precursor for hepatic triglyceride synthesis (Eaton, Steinberg & Berman, 1965; Carlson & Bally, 1965; Havel, Kane, Balasse, Segel & Basso, 1970; Boberg, Carlson & Freyschuss, 1972) . The outflux of triglyceride from the plasma can also be influenced by the rate of FFA release, which seems to regulate the lipoprotein lipase enzyme in adipose tissue (Nikkila & Pykalisto, 1968; Shafrir & Biale, 1970) . The activity of this enzyme determines the rate of removal of plasma triglycerides (Salaman & Robinson, 1966) . In order to study the mechanisms responsible for hypertriglyceridaemia, it is therefore necessary to assess the kinetics of plasma FFA and triglyceride transport simultaneously.
The relation between the hepatic output of triglycerides and plasma FFA turnover has been examined in man by Havel et al. (1970) , Boberg, Freyschuss & Carlson (1970) and Boberg et al.
(1 972). The techniques used by these authors provide the most accurate means of determining this relation but have certain drawbacks. First, the cannulation procedures are not without risk. Secondly, the differences in triglyceride concentration between portal and hepatic venous plasma are small and close to the limits of precision of the analytical methods currently available.
The alternative method for estimation of plasma FFA and triglyceride transport is based on measurements of the decay rates of labelled fatty acids and endogenously labelled triglycerides after intravenous administration of a tracer dose of labelled fatty acids (Havel, 1961 ; Nestel, 1965 ; Eaton, Berman & Steinberg, 1969) . This convenient technique, however, involves calculations based on a number of assumptions (see the Discussion section) which have not been fully proven.
In the present study an attempt is made to evaluate the validity of these assumptions and to test the possible use of this tracer technique to measure plasma FFA and triglyceride transport kinetics in man. The complex relation between the plasma concentrations of these compounds and their transport kinetics has also been explored.
SUBJECTS A N D EXPERTMENTAL P R O C E D U R E S
Twenty-seven normolipaemic healthy volunteers (mean age 42 years, range 17-62) and ten patients with hypertriglyceridaemia (mean age 43 years, range 35-66) were studied. All the subjects had relative body weights below 120% of their ideal body weight (Documenta Geigy tables). Clinical and laboratory investigations showed no evidence of thyroid disease, liver disease or excessive alcoholism. None of these subjects was taking any drug known to affect lipid metabolism, including oral contraceptives.
The normal group comprised twelve males and fifteen females, all of whom had normal oral glucose tolerance. (Fasting plasma glucose < 5-6 mmol/l, 60 min value < 10.0 mmol/l and 120 min value ~7 . 8 mmol/l.) The hypertriglyceridaemic subjects were selected as volunteers from a larger group. They included four non-diabetic subjects with type IV idiopathic hypertriglyceridaemia (Fredrickson, Levy & Lees, 1967) and four maturity-onset diabetic subjects with fasting hypertriglyceridaemia. All these patients had plasma triglyceride concentrations over 2 mmoljl.
All the subjects were given an isocaloric diet providing 146.5 H/kg ideal body weight, of which 38% was carbohydrate, 45% fat and 17% was protein, for a period of 2 weeks. They were then admitted to the metabolic ward, where the diet was continued. During this period the body weight and fasting plasma lipids were recorded on alternate days. Studies were only performed when the body weight and plasma lipids had remained steady for at least 1 week. After the patient had fasted overnight, an indwelling needle was inserted into an antecubital vein, which was used for infusion. A catheter was inserted into the superior vena cava via a contralateral arm vein for venous sampling.
[I-'4C]Palmitate and [2-3H]palmitate were obtained from The Radiochemical Centre, Amersham, Bucks., U.K. The fatty acids were purified by thin-layer chromatography (Boberg, 1966) , dissolved in heptane and stored at -20°C. On the morning of the study, an aliquot was taken and the heptane evaporated under nitrogen. The residue was then dissolved in 0-5 ml of aq. 50% (v/v) ethanol. The potassium salt of palmitic acid was then prepared at 70°C by neutralizing this solution with potassium hydroxide (10 mmol/l) added from a microburette. The solution was then cooled to room temperature and mixed with 2 ml of sterile 20% (w/v) human albumin solution in water. Aliquots of the isotoFes were diluted in saline and either infused by using a continuous infusion syringe, or given as a pulse injection.
Further details of the experimental procedures are described in detail in the Results section. (1970) . Plasma lipoproteins were also separated by electrophoresis (Chin & Blankenhorn, 1968) . Isolation of the radioactive lipids from the plasma and lipoprotein fractions was performed as follows. Plasma (4 ml) was extracted in 20 ml of Dole's (1956) extraction mixture and the heptane phase was then separated. The radioactive FFA was extracted from the heptane phase with alkaline ethylene glycol as described by Kaplan (1970) . A portion (9 ml) of the heptane phase was transferred to extraction tubes together with 2 ml of NaOH (0.1 mol/l) dissolved in ethylene glycol. The stoppered tubes were then shaken continuously on a rotor mixer for 10 min. This procedure allowed the extraction of FFA into the alkaline ethylene glycol phase and left the esterified fatty acids in the heptane phase. The heptane phase was then removed and the ethylene glycol phase was washed with heptane and transferred quantitatively into radioactivity counting vials containing 10 ml of scintillation fluid [dioxan 750 ml, ethylene glycol 150 ml, 2,5-diphenyloxazole (PPO) 10 g, 1,4-bis-(4-methyl-5-phenyloxazol-2-yl)benzene (POPOP) 0.45 g and naphthalene 45 g]. The radioactivity was determined in a Packard TriCarb liquid-scintillation counter with appropriate internal standard to correct for quenching and to determine the counting efficiency. Six recovery experiments using albumin-bound 14C-labelled fatty acids added to plasma showed that between 96 and 98% of the fatty acids were extracted into the ethylene glycol phase.
METHODS
The heptane layer remaining after fatty acid extraction with ethylene glycol was transferred quantitatively into extraction tubes and the heptane was removed under nitrogen. The dried lipids were then re-extracted in 10 ml of chloroform and shaken with 2 g of silicic acid to extract the phospholipids. The solvent containing the triglycerides was then filtered into a counting vial and the chloroform was evaporated. A portion (10 ml) of scintillation fluid (1 litre of toluene containing 4 g of POP and 100 mg of POPOP) was added and the radioactivity determined in a Packard Tri-Carb liquid-scintillation counter. The separation and the recovery of radioactive triglycerides was checked by thin-layer chromatography (Boberg, 1966) . In six experiments 90-96% of the radioactivity was in the triglyceride fraction. Thin-layer chromatography of the original chloroform extract showed in six experiments that 92-95% of the plasma triglyceride radioactivity was recovered in the final solution used for radioactivity counting.
RESULTS

Measurement of plasma FFA fluxes
Plasma FFA fluxes were determined in eight normal subjects and eight patients with hypertriglyceridaemia. Each patient received a pulse injection of [3H]palmitate (100 @) and a continuous infusion of [14C]palmitate (25 pCi) simultaneously. The alb~min-[~H]palmitate complex was diluted in 5 ml of saline and given as a pulse injection. The [14C]palmitate was diluted in 25 ml of saline and infused at a rate of 0-2 pCi/min. Samples of blood were collected into heparinized tubes at 2 min intervals for 30 min. Thereafter samples were withdrawn every 10 min for another 2-3 h. The blood samples were kept on ice until the plasma was separated and assayed for FFA specific radioactivity. Fig. l(a) shows the time-course of plasma FFA specific radioactivity disappearance in a normal person receiving a pulse injection. The plasma specific radioactivity curves plotted semi-logarithmically showed a biphasic decay, a rapid phase which occupied the first 30-46 min and a slower decay phase which remained exponential for the rest of the study period. This pattern of decay curves suggested that plasma FFA equilibrates with another compartment. It was therefore decided to analyse the results of the pulse-labelling technique by using a two-compartment model similar to that described by Gurpide, Mann & Lieberman (1963) and Gurpide, Mann & Sandberg (1964) , and which has been applied previously to plasma FFA transport (Eaton et al., 1969) . This model, as shown in Fig. I(a) , assumes that plasma FFA (compartment A) equilibrates with another compartment (B) reversibly. The plasma FFA radioactivity curves were then resolved into two exponentials (Ca and Cb) and the rate constant for each exponential was determined. This technique enabled us to calculate the total FFA flux, the irreversible transport of FFA, and the exchange rates between the plasma FFA pool and other compartments. The mathematical equations used to calculate these parameters have been discussed by Gurpide et a/. (1963) and Gurpide et ul. (1964) . The results of these measurements are shown in Table 1 and Fig. 2 . It is important to point out that these calculations were based on the assumption that the two compartments have a common inlet and outlet and that this is only through the plasma compartment.
During the continuous infusion of [14C]palmitate, the plasma FFA specific radioactivity reached equilibrium between 30 and 40 rnin after the start of the infusion. Thereafter the specific radioactivity remained constant till the end of the infusion period (Fig. Ib) . In four subjects the infusion period was prolonged for 6 h and in these subjects the plasma FFA specific radioactivity reached equilibrium after 40 min and remained constant throughout the infusion period (Fig. 3) . These results suggest that after 3 0 4 0 min from the start of the infusion, the plasma FFA radioactivity was in equilibrium with the other compartments. To test the possible equilibration of the plasma compartment with interstitial lymph, samples were obtained through a cannula introduced in a superficial lymphatic vessel on the dorsum of the foot and the specific radioactivity of FFA in this fluid was determined. Fig. 3 shows that during the second hour of the infusion period the specific radioactivity of FFA in the interstitial lymph was equal to that of the plasma and remained constant during the rest of the infusion period. The plasma FFA flux was determined from the equation: Table 1 shows these values in eight normal subjects and eight hypertriglyceridaemic patients. The results indicate that values of FFA flux measured by the continuous infusion technique agree closely with the values of irreversible FFA flux determined from the two-pool model with a single-pulse injection.
Measurement of plasma triglyceride transport kinetics
Turnover measurements. Plasma triglyceride turnover rates were determined in eight normal subjects and eight patients with hypertriglyceridaemia, two different techniques being used in the same subject. In the first procedure, plasma very-low-density lipoprotein (VLDL) triglycerides were labelled endogenously during a 2 h infusion of a tracer amount of ['"CIpalmitate and the fractional transport rate of endogenous triglycerides was determined from the decay of the plasma VLDL triglyceride specific radioactivity after stopping the infusion. In the second procedure, plasma VLDL triglycerides were prelabelled endogenously with [14C]palmitate and withdrawn to be re-infused into the same subject 2 weeks later. The decay rate of radioactivity in the re-infused VLDL triglycerides was used to determine the fractional transport rate of endogenous triglycerides.
Each subject received a continuous infusion of [14C]palmitate (100 pCi) over a 2 h period. The infusion was stopped and 1 h later 200 ml of plasma was withdrawn and the plasma VLDL fraction was isolated by ultracentrifugation. This fraction was dialysed for 24 h against physio. logical saline containing EDTA (0.1 mmol/l) and stored at 4°C for re-infusion 2 weeks later. Blood samples were also collected every 30 min for a period of 12 h after stopping the infusion Thereafter samples were withdrawn every 3 h for the rest of the 24 h study period. Plasma was immediately separated and the VLDL fraction in these samples was isolated by ultracentrifugation (Hatch & Lees, 1968) . The specific radioactivity in the VLDL triglyceride was determined and plotted versus time on semilogarithmic paper. Results were analysed only in those patients in whom plasma triglyceride concentration remained within 10% of the mean, during the experimental period. Two weeks later, the VLDL fraction stored at 4°C was warmed to 37°C for 30 min and passed through a Millipore filter to be given intravenously as a single-pulse injection to the
original donor. The 2 weeks period was found to be essential to avoid the residual radioactivity remaining from the original infusion, The amount of triglyceride used to infuse each subject was less than 0.375 mmol and was therefore considered negligible in relation to the total plasma lipids. The radioactivity in plasma VLDL triglyceride was determined and plotted against time on semilogarithmic scale. decay rate of radioactivity was exponential during the first 12 h after stopping the infusion. After this period, a deviation of the plot from linearity was observed in some of the patients and the decay rate became slower. Fig. 4 shows that re-infused VLDL triglycerides exhibited a linear decay during the 10 h period after injection. The strict parallelism and linearity of the decay curves of endogenously labelled triglycerides and re-infused triglyceride suggested that negligible recycling occurred from plasma triglyceride FFA into the triglyceride pool during this period. Plasma VLDL triglyceride turnover rates were calculated from the fractional transport rate and the plasma VLDL triglyceride pool, from the following equation :
Turnover rate hmol h-kg-') = K x plasma VLDL triglyceride concentration (pmol/ml) x 50
In this calculation, the distribution space of VLDL triglyceride was assumed to be equal to the plasma volume (50 ml/kg body weight). This assumption was validated by the observation that the initial volume of isotope dilution of prelabelled lipoprotein calculated from the ordinate intercept and the injected radioactivity was equal to the plasma volume calculated as 50 rnl/kg body weight. Table 2 shows the values of plasma VLDL triglyceride turnover rate measured in the same subject by the two previously described techniques. The values of the turnover rates in both normal and hypertriglyceridaemic subjects showed close agreement between the two techniques employed. During the decay of re-infused VLDL triglyceride radioactivity was observed to appear in the plasma FFA fraction with peak values occurring at 15-20 min; thereafter a progressive decay occurred. This observation suggested that fatty acids recycle from plasma VLDL triglyceride into the plasma FFA pool. In order to quantify the magnitude of this recycling, a pulse injection of [3H]palmitate was given simultaneously with the 14C-labelled VLDL triglycerides. The I4C and 3H data were then used to calculate the magnitude of recycling of plasma triglyceride fatty acids into the plasma FFA pool, by the method described by Steele (1971) . The results shown in Table 2 indicate that less than 20% of the total plasma VLDL triglyceride transport is converted directly into plasma FFA. Since the plasma FFA turnover is about five to six times that of the VLDL triglyceride, recycling can therefore account for less than 5% of the total plasma FFA transport rate.
Relation between the triglyceride turnover in the unfractionated plasma and in the individual lipoprotein classes. In two normal subjects and in four patients with hypertriglyceridaemia, the plasma lipoprotein fractions were isolated after endogenous labelling with [14C]palmitate infusion. The specific radioactivity of the triglycerides in each of these fractions was determined. Fig. 5 shows that radioactivity was immediately detected in the VLDL triglycerides and increased to reach a maximum value at 3 h. Thereafter the specific radioactivity declined in this fraction exponentially. During this decline, radioactive triglycerides were accumulating in the low-density lipoprotein (LDL) fraction and reached a peak 5-6 h after stopping the infusion, to be Followed by a slow and progressive decline. Minimal changes were observed in the highdensity lipoprotein (HDL) triglycerides during this experimental period.
In order to determine the relation between total plasma triglyceride transport and the VLDL triglyceride transport, the specific radioactivity of triglycerides was determined in both unfractionated plasma and in the VLDL Fraction OF the same samples. Total plasma triglyceride transport was calculated from the Fractional turnover rate determined from total plasma triglyceride radioactivity and the total plasma triglyceride pool. The plasma VLDL triglyceride radioactivity was used to determine the fractional turnover of VLDL triglycerides. The plasma VLDL triglyceride turnover values were then calculated from the fractional turnover rate and the plasma VLDL triglyceride pool. Table 3 shows that measurement of plasma triglyceride turnover with unfractionated plasma agreed to within 10% with the values obtained From VLDL triglycerides. These results suggest that measurement of total plasma triglyceride turnover during the experimental period reflects mainly the transport of VLDL.
Relationship between plasma triglyceride concentration and its transport kinetics. Fig. 6 shows the relationship between plasma triglyceride concentration and turnover rates in twenty-seven normal subjects. The plasma triglyceride turnover rates were determined in these subjects by the endogenous labelling technique with 14C-labelled fatty acid as described above. Statistical analysis of this relationship using the linear regression system obeying two separate regimes separated the points into two groups (Quandt, 1958) . Nineteen points were situated in the left- hand group ( y = 2-7774+0.4746x) and eight points in the right-hand group ( y = 1*6560+ 2.9641~). These results indicated that the relationship between plasma triglyceride concentration and its turnover rate was not linear at all levels and could therefore be represented by a curved line, suggesting that the removal of plasma triglyceride follows a saturable system.
In order to test this possibility, four normal subjects and four diabetic patients received infusions of triglyceride emulsion at different rates and the plasma triglyceride levels were monitored during this period. A commercially available fat emulsion (20% Intralipid, AB Vitrum, Stockholm, Sweden), clinically used for parenteral nutrition, was found to be suitable for intravenous administration without clinical side-effects. After an overnight fast, the subjects received a priming dose of Intralipid containing 0.1-0.3 mmol of triglyceride/kg body weight over 2 min, followed by a continuous infusion during three to six consecutive periods with increasing amounts of Intralipid during each period. The duration of each infusion period was 60 min. Blood was withdrawn from the contralateral arm catheter for determination of plasma triglyceride concentration. First-order removal kinetics were considered to exist when the plasma triglyceride concentration remained at a constant value during the infusion period. Zero-order removal rates were considered to operate when the plasma concentration increased linearly during the infusion.
The removal rate of plasma triglycerides ( V ) was then calculated from the equation V (pmol min-l 1-I) = (I/P)-k, where Z = infusion rate of Intralipid during that period (pmol/min), P = plasma volume in litres and k = rate of increase in plasma triglyceride concentration during each infusion period kmol min-l 1-l). The value of k was equal to zero when the plasma triglyceride concentration remained constant during the infusion. In normal subjects, infusion of Intralipid at rates below 300 ,umol/min produced stable concentrations of plasma triglycerides, suggesting that the removal rates had been increased proportionally. However, when the infusion rates were further increased the plasma triglyceride concentration increased linearly with time. Fig. 7 shows the relationship between removal rates of Intralipid and the plasma triglyceride concentration in normal persons and in diabetic subjects. In both groups the removal rates of Intralipid were increased with increases in plasma triglyceride concentration. This relationship remained until a critical concentration was reached when the removal mechanisms became saturated. Further increases in plasma triglyceride concentration beyond this value did not produce concordant changes in the removal rates. The maximal removal rates of Intralipid were not significantly different in diabetic and normal subjects. However, at each plasma concentration the removal rates of Intralipid were higher in normal subjects than in the diabetic patients.
The relation between plasma triglyceride concentration and its production was also investigated. The effects of increasing the plasma triglyceride level on the hepatic conversion of plasma 4C-labelled FFA into 14C-labelled VLDL triglycerides was measured in four normal subjects.
Each received a pulse injection of Intralipid followed by a continuous infusion at rates between 100 and 200 pmol/min. These infusion rates were chosen to achieve a steady plasma concentration during the infusion period. Three hours later, when the plasma FFA and triglyceride concentrations were constant, an infusion of ['4C]palmitate was started and continued for another 2 h. The conversion rate of ''C-labelled FFA into triglycerides was measured from the specific radioactivity of plasma FFA at equilibrium and the rate of increase of the label in plasma triglycerides during the last hour of the l4C-1abelled FFA infusion period (Ryan & Schwartz, 1965) . The measurements were repeated a week later, a continuous infusion of saline instead of Intralipid being used. Table 4 shows that elevation of plasma triglycerides reduced the incorporation of plasma FFA into triglycerides. The magnitude of this reduction appears to be proportional to the degree of hypertriglyceridaemia.
D I S C U S S I O N
The transport kinetics of plasma FFA and triglycerides have been extensively studied in animals (Baker & Schotz, 1964; Nikkila, Kekki & Ojala, 1966; . The behaviour of these lipid moieties, however, seems to exhibit marked interspecies differences (Baker & Schotz, 1964; Havel, 1961; Farquhar, Gross, Wagner & Reaven, 1965 ) and hence it is not possible to extrapolate from these animal experiments directly to man. Furthermore, animal models of human disease are not always available. It is therefore important to employ methods that can be used with minimal inconvenience to the patient, to study the transport kinetics of these molecules in man in order to evaluate the pathogenic mechanisms that alter the plasma levels of these compounds and their relationship to human disease. During the last 10 years labelled FFA has been used to quantify the transport rates of plasma FFA and triglycerides in man (Havel, 1961 ; Farquhar et al., 1965; Nestel, 1965; Eaton et al., 1969; Quarfordt & Goodman, 1966) . These methods are based on the responses of these lipid moieties in plasma after the administration of radioactive fatty acids. Though the techniques involved do not cause inconvenience to the patient, they have the disadvantage that a number of assumptions are involved in the calculation of plasma FFA and triglyceride transport rates. Eaton et al. (1969) , using labelled fatty acids administered intravenously, suggested that the transport of plasma FFA could be represented by a two-compartment model. In this model, plasma FFA transport was differentiated into two metabolic pathways : irreversible loss from the plasma, and reversible exchange with another compartment. This suggestion, however, was not new since the earlier studies of Fredrickson & Gordon (1958) and Dole (1958) have shown that a significant fraction of FFA leaving the plasma re-enters it as FFA from a second compartment. The results of our investigations in normal and hyperlipaemic subjects also confirm these previous findings. In all the patients studied the disappearance curves of plasma FFA specific radioactivity after a pulse injection of labelled palmitate showed a biphasic decay consistent with the two-pool model (Gurpide et al., 1963 (Gurpide et al., , 1964 .
To determine the rates of irreversible loss and reversible exchange between the plasma FFA compartment and the second compartment, Eaton et al. (1969) had to postulate a common inlet to both compartments. This assumption was necessary in their calculation since the second compartment was not sampled at the same time (Gurpide et al., 1963 (Gurpide et al., , 1964 . To validate this assumption it is necessary to obtain some information about the anatomical location of this second compartment. Eaton et al. (1969) suggested that the flow from the second compartment to the plasma represents recycling of fatty acids from plasma triglyceride fatty acids as well as between plasma and extravascular FFA pools. These authors labelled the plasma triglyceride in uitro and re-infused it into two normal subjects and determined the magnitude of this recycling. In their studies as much as 50% of the total plasma triglyceride transport was converted rapidly into plasma FFA, suggesting that plasma triglyceride fatty acid might be an important part of the reversible exchange pool. In the present study, we have re-evaluated this possibility using lipoprotein triglycerides labelled in uiuo in eight normal subjects and eight patients with hypertriglyceridaemia. Our results suggest that less than 20% of the plasma VLDL triglyceride transport was converted into plasma FFA and that this pathway can account for less than 5% of the plasma FFA transport rate. The contradiction between our results and those of Eaton et al. (1969) can be attributed to the difference in the labelling techniques. The labelling technique used in uifro by Eaton et al. (1969) might have produced labelled lipoproteins with artificial kinetics. In fact, they reported that 15% of the label in their lipoprotein decayed more rapidly than any known lipoprotein species. Our results therefore suggest that recycling of fatty acids from the plasma triglycerides into the plasma FFA pool can account for only a minor fraction of the reversible exchange rate. Furthermore, the magnitude of this pathway was similar in the normolipaemic and hypertriglyceridaemic subjects and hence cannot be of major importance in the pathogenesis of hypertriglyceridaemia.
Another important source of FFA exchange with the plasma is the extravascular space. During intravenous infusion of [14C]palmitate radioactivity was recovered in the FFA fraction obtained from a sample of interstitial lymph. The FFA specific radioactivity in this fiuid obtained 1 h after the start of the infusion was found to be equal to that of the plasma and remained so for the rest of the infusion period. These results suggest that the FFA fraction in the interstitial space is in rapid equilibrium with the plasma and that there is no independent inlet to this compartment except through the plasma. Calculation of plasma FFA transport rates from the plasma FFA decay curves with the two-compartment model is therefore possible. With this technique the exchange transport rate of FFA between the plasma and extravascular space accounted for about 20% of the total transport, and there was no marked difference between the normal subjects and patients with hypertriglyceridaemia.
In assessing the relation between the plasma FFA and triglyceride transport kinetics, it is important to obtain information about the actual FFA flux available for tissue oxidation and storage. The latter can be determined by using the two-compartment model. Alternatively, the net flux of FFA which represents this fraction can be determined if the labelled fatty acid is administered by continuous infusion. During the second hour of the infusion period the specific radioactivity of plasma FFA was in equilibrium with that of the interstitial lymph and flux rates calculated on the basis of this value will reflect the net through flux. This technique is more convenient to apply in clinical investigations since it involves minimal mathematics and does not require rapid sampling essential for accurate construction of the biphasic decay curves.
In the present study plasma triglyceride turnover rates were calculated from the fractional disappearance of triglycerides labelled endogenously with [ ''C]palmitate. This calculation was based on four main assumptions.
The first assumption is that there is no significant recirculation of fatty acids from plasma triglycerides into the plasma FFA pool, and therefore into the plasma triglyceride pool, to affect the disappearance curve of plasma triglycerides. To test this hypothesis the turnover rates were measured in groups of normal and hypertriglyceridaemic subjects by using the endogenous labelling technique and compared with the results of another technique in which prelabelled lipoprotein triglycerides were re-injected into the same donors. The strict parallelism between the specific radioactivity disappearance curves and the close agreement between the turnover values determined by the two techniques indicate that recycling is minimal and hence does not affect the triglyceride radioactivity curves. To quantify this pathway more precisely the plasma FFA radioactivity curves after injection of 14C-prelabelled VLDL triglycerides and [3H]palmitate were analysed. The results showed that less than 5% of plasma FFA flux can be derived from this pathway, When one considers that the transport rate of plasma triglycerides represents less than 20% of the total plasma FFA transport, it becomes apparent that this recycling will produce negligible effects on the plasma triglyceride specific radioactivity curves during the experimental period.
A second assumption upon which this method is based considers the plasma triglyceride pool to behave as if it were a single compartment. This assumption is not completely valid, since about 30% of the triglycerides in the plasma is present in HDL and LDL, both of which possibly turn over at a much slower rate than VLDL, the main carrier of plasma triglycerides in the post-absorptive state. In order to evaluate the magnitude of error introduced by this assumption, results obtained from studies in which the plasma lipoprotein fractions were isolated and the turnover of triglycerides in the VLDL fraction was determined, were compared with data obtained from unfractionated plasma. The results indicate that the observed rates of total plasma triglyceride decay reflect primarily the turnover of triglycerides in the VLDL fraction but slightly underestimate it due to its conversion into LDL and possibly HDL. However, the use of the total plasma triglyceride pool instead of the VLDL pool in calculating transport has the opposite effect, so that the magnitude of the error introduced by these approximations is less than 5%. Hence separation of the plasma lipoprotein classes was not considered necessary in our further studies. These observations confirm the report of Nikkila & Kekki (1971a) .
The third assumption upon which the calculation of turnover rate is based considers that the distribution space of circulating triglycerides was equal to the plasma space. We observed that the initial volume of isotope dilution after injection of prelabelled triglycerides was equal to the plasma volume calculated on the basis of body weight.
The fourth assumption considers the patient to be in a steady state and that the input and output of triglycerides are equal, and thus can be equated to the turnover rate. Plasma triglyceride concentration was therefore monitored in each patient during the experimental period and only the results of those patients who showed variations of less than 10% were accepted for analysis.
In the present study, the rate constants for total plasma triglyceride transport in normal subjects ranged between 0-21 1 and 0-492. These values are comparable with those of Friedberg, Klein, Trout, Bogdonoff & Estes (1961) , who used an integration method, and those reported by Reaven, Hill, Gross & Farquhar (1965) and Nikkila & Kekki (1971a) , who used the [3H]glycerol-labelling method.
The present study suggests a complex relation between the plasma triglyceride concentration and its transport kinetics. On the one hand, the plasma triglyceride concentration may be determined by the rates of input and output from the plasma. On the other hand, the plasma level of this compound may influence its own production and clearance. Plotting the plasma triglyceride concentration against its turnover rate in normal subjects demonstrated a linear relationship at low concentrations, suggesting that the plasma triglyceride concentration is determined by the rate of input of triglyceride into the plasma pool. Increases in plasma triglyceride influx above a certain range produced disproportionately high triglyceride concentrations. These findings indicate that the removal of triglyceride conforms to a saturable system. To test this possibility further normal subjects were infused with Intralipid to produce various levels of hypertriglyceridaemia. When the rate of infusion of Intralipid was increased over 300 pmol/min, the plasma triglyceride level increased steeply. The saturability of the triglyceride clearing systems has been previously shown by Reaven et ul. (1965) and Nikkilii & Kekki (1971a), using isotopic techniques, and by Hallberg (1965) using Intralipid. In the present study the saturability of the triglyceride clearing system was evident in both normal and hypertriglyceridaemic subjects.
During experimental hypertriglyceridaemia, it was observed that increases in plasma triglyceride concentration were associated with progressive increases in the removal rate of Intralipid from the plasma. These findings were evident both in the normal and hypertriglyceridaemic subjects, and suggest that the plasma level can influence the clearance rate until the removal mechanism becomes saturated. The observation that increases in plasma triglyceride concentration inhibited the conversion rate of plasma FFA into triglyceride indicates that the plasma triglyceride concentration also exerts a regulatory feedback control upon its own production. The latter observation is supported by Siperstein & Fagan (1964) , who reported a reduction in hepatic lipoprotein synthesis in slices obtained from rats previously infused with lipoprotein, and Cooper & Margolis (1971) , who observed a reduction in synthesis of triglyceride in hepatocytes incubated in uitro with increasing concentrations of lipoproteins.
It was concluded that any attempt to interpret the turnover measurements would be meaningless without concomitant consideration of the prevailing plasma triglyceride concentrations. Such a conclusion was previously reported by Reaven et ul. (1965) and Nikkila & Kekki (1971a) .
A simple way of expressing this relationship is to construct the saturation curve of the normal subjects ( Fig. 6a) and to examine any abnormal material against this background. Fig. 6(b) is a schematic representation of the possible mechanisms that can produce hypertriglyceridaemia, based on this approach. This technique was originally described by Nikkila & Kekki (1971a) and was found by these authors to give satisfactory information about the various mechanisms responsible for hypertriglyceridaemia (Nikkila & Kekki, 1971 b) .
An alternative approach, initially postulated by Reaven et ul. (1965) , employs enzyme kinetic equations to characterize plasma triglyceride transport. Despite several reservations concerning the use of this model, in view of the multiple compartments involved, the results in our study and in those of others Nikkila & Kekki, 1971b) were consistent with such kinetics. In analogy with the Michaelis-Menten formulation, the plasma triglyceride concentration ( S ) is determined by its turnover rate (V), the rate of maximal removal (V,,,) , and the K,,, value, which is the concentration at which the turnover is operating at half-maximal velocity.
In each group of patients studied, the relationship between Sand S/ Vwasconstructed. Fig. 8 shows this relationship in normal subjects. The close fit of the points representing these subjects was tested using quadratic and linear regression equations. The results indicated that the linear regression equation fitted significantly better to these points than the quadratic equation, suggesting that the V,,,. is uniform in the normal population. The V,,,. was also similar to the control value in all the hypertrigtyceridaemic patients (Kissebah, Harrigan & Wynn, 1973 ; except in those patients with type IV hyperlipoproteinaemia (Adams, Kissebah, Harrigan, Stokes & Wynn, 1974) . In the latter group, the V,,,, was slightly higher than the control value and was decreased to normal values after reduction of the plasma triglyceride concentration. In both normal subjects and in patients with hypertriglyceridaemia sequential elevation in serum triglycerides was induced by Intralipid infusion. In both groups the maximal removal rates of Intralipid were equal. These observations suggested that the V,,,. is not of major significance in the mechanisms responsible for hypertriglyceridaemia. When the rate of delivery of Intralipid was kept below the maximum removal rate it was evident that the efficiency of the clearing mechanisms was lower in the hypertriglyceridaemic patients than in the normal subjects. It was therefore considered that the K,,, would be the best criterion ., female subjects.
to describe the interrelationship between plasma triglyceride concentration and the efficiency of the plasma triglyceride clearing mechanisms.
In conclusion, our results validate the assumptions involved in the calculation of plasma FFA and triglyceride kinetics from the plasma specific radioactivity curves after the administration of a tracer dose of 14C-labelled fatty acid. They also indicate a complex relation between plasma triglyceride concentration and its transport kinetics. The plasma level of triglyceride is determined by the rates of input and output from the plasma. The plasma concentration can, however, regulate its own production and clearance. To determine the mechanisms responsible for hypertriglyceridaemia it is therefore necessary to construct the relationship between plasma triglyceride concentration and its turnover rate in normal subjects and to examine any abnormal material against this background. Evidence is also presented concerning the suitability of the 
